参考文献/References:
[1] 赫捷,邵康.中国食管癌流行病学现状、诊疗现状及未来对策[J].中国癌症杂志,2011,21(7):501-504.
[2] 洪瑞,方伟群,黄宏辉,等.食管癌和贲门癌3 682例外科治疗分析[J].河北医药,2010,32(14):1876-1877.
[3] 左顺庆,夏松成,陈友根,等.1 283例食管癌和贲门癌的外科治疗[J].临床外科杂志,2011,19(3):215-216.
[4] 尤静,朱广迎.食管癌放化疗相关进展[J].中国癌症防治杂志,2014,6(4):327-331.
[5] WEBSTER M K,GOYA L,GE Y,et al.Characterization of SGK,a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucoeortieoids and seruln[J].Mol Cell Bial,1993,13(4):2031-2040.
[6] WANG L,ZHOU C,ZHU Q,et al.Up-regulation of serum-and glucocorti-coid-induced protein kinase 1 in the brain tissue of human and experimental epilepsy[J].Neurochem Int,2010,57(8):899-905.
[7] WEI L.Immunological aspect of cardiac remodeling:T lymphocyte subsets in lnflammation-mediated cardiac fibrosis[J].Exp Mol Pathol,2011,90(1):74-78.
[8] CREEMERS E E,PINTO Y M.Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart[J].Cardiovasc Res,2011,89(2):265-272.
[9] 李陕区,赵仁礼,巩丽,等.酪氨酸蛋白磷酸酶样A 结构域2在食管鳞状细胞癌组织中的表达及其临床意义[J].新乡医学院学报,2014,31(11):256-259.
[10] 郑娇,杨敏,苗艳菊,等.蛋白激酶SGK1在高血压性心脏纤维化中的表达及影响[J].心肺血管病杂志,2012,31(3):204-208.
[11] BELAIBA R S,DJORDJEVIE T,BONELLO S,et al.The serkun-and glucocorticoid kinase Sgk-1 is involved in pulmonary vascular remodeling:role in redox-sensitive regulation of tissue factor by thrombin[J].Circ Res,2006,98(6):828-836.
[12] 张舒精,师水生,田慧.肝纤维化大鼠和糖皮质激素调节蛋白激酶1的表达及坎地沙坦对其的影响[J].中国药物与临床,2011,11(10):1152-1154.
[13] WALLACE K,LONG Q,FAIRHALL E A,et al.Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes[J].J Cell Sci,2011,124(Pt3):405-413.
[14] 王学彬,王芳芳,张晓敏.大黄酸通过抑制SGK1信号通路防治糖尿病大鼠肾纤维化[J].滨州医学院学报,2013,36(8):249-252.
[15] CHENG J,WANG Y,MA Y,et al.The mechanical stress-activated serum,glucocorticoid-regulated kinase 1 contributes to neointima formation in vein rafts[J].Circ Res,2010,107(10):1265-1274.
相似文献/References:
[1]原志庆,王凤荣,吴国祥,等.食管癌切除标本断端残留癌的流式细胞分析[J].新乡医学院学报,1991,8(01):012.
[2]彭明轩,张一峰.食管癌与贲门癌238例手术治疗及其并发症分析[J].新乡医学院学报,1992,9(01):048.
[3]刘玉梅,申维玺,姚卫华,等.氟尿嘧啶合并醛氢叶酸治疗食管癌疗效评价[J].新乡医学院学报,1995,12(02):123.
[4]原志庆,许春雷.瘤体内DNA倍体异质性与食管鳞状细胞癌病理特性的关系[J].新乡医学院学报,1995,12(01):005.
[5]常银江,马森林,王守义,等.上段食管癌切除后食管床内胃食管颈部吻合术[J].新乡医学院学报,1996,13(02):143.
[6]王俊英,李国群,董长宪,等.食管癌合并糖尿病患者的围手术期处理[J].新乡医学院学报,1996,13(02):151.
[7]陈国荣.中晚期食管癌夹心治疗近期疗效分析 [J].新乡医学院学报,1997,14(02):150.
[8]李慧清,李汉臣,杨红伟,等.不同食管胃吻合方法术后生活质量分析[J].新乡医学院学报,1997,14(03):213.
[9]郭玉军,吴阶清,刘新秋,等.双介入疗法治疗晚期食管癌[J].新乡医学院学报,1997,14(03):287.
[10]乔 刚 李汉臣 席红军 王忠民 崔 玉 韩培立 赵宝生.食管癌患者手术前后细胞免疫的变化[J].新乡医学院学报,1999,16(04):308.